⏱ News is delayed by 15 minutes. Sign in for real-time access.
Sign in
CRBU News
Caribou Biosciences, Inc. Common Stock
Form 8-K
sec.gov
CRBU
Caribou Biosciences Reports Second Quarter 2026 Financial Results and Provides Business Update
globenewswire.com
CRBU
Gene Editing Therapeutics: Transforming Biopharmaceuticals with 12.5% CAGR Growth Forecast
globenewswire.com
CRSP
NTLA
EDIT
BEAM
SANG
CELC
CRBU
PRME
Caribou Biosciences to Participate in the H.C. Wainwright 4th Annual Cell Therapy Virtual Conference
globenewswire.com
CRBU
Form 8-K
sec.gov
CRBU
After CAR-T, the Next Frontier in Cancer Immunotherapy May Belong to a Different Immune Cell
globenewswire.com
GTBP
FATE
NKTX
CMPX
CRBU
Form 8-K
sec.gov
CRBU
Caribou Biosciences Reports Long-Term Vispa-cel Data in Second-line Large B Cell Lymphoma at EHA 2026
globenewswire.com
CRBU
Caribou Biosciences Reports Dose Escalation Durability Data for CB-011 at the 2026 European Hematology Association (EHA) Annual Meeting
globenewswire.com
CRBU
Caribou Biosciences to Participate in the 2026 Jefferies Global Healthcare Conference
globenewswire.com
CRBU